Dietary Carotenoid Lutein Reduces Atherosclerotic Lesion Formation In Mice

WASHINGTON, April 18, 1999 -- The carotenoid antioxidant lutein can significantly reduce atherosclerotic lesion formation in mice, according to a study presented today at the Federation of American Societies for Experimental Biology 1999 annual meeting.

"The area of arterial lesions in the mice that were fed chow with lutein was reduced significantly in the pilot study," reported Dr. James Dwyer, Professor of Preventive Medicine, University of Southern California. "With further research, we plan to determine whether or not the intake of foods rich in lutein slows the progression of the disease that leads to most heart attacks and strokes."

Researchers from the USC Department of Preventive Medicine and the Atherosclerosis Research Unit, University of California at Los Angeles studied the effect of inclusion of the antioxidant lutein in the diet of apolipoprotein E (apoE) null mice. Groups of apoE null mice were maintained on a diet containing zero or 0.2% (by weight) lutein for four weeks. Researchers then sectioned and examined the areas of the aortic lesions and observed that the mice on the lutein-enriched diet had significantly reduced arterial lesion area.

Mice that are "null" or deficient in apoE develop atherosclerotic lesions very rapidly in the aortic arch. Inactivation of the apoE gene in mice leads to a prominent increase in blood cholesterol and triglyceride levels and the development of premature atherosclerosis.

Studies are already under way to examine a larger group of apoE null mice. Further research is needed to determine the role that lutein may play in the prevention of atherosclerotic lesions in humans.

Lutein is found in dark leafy green vegetables like spinach and kale. Research concerning lutein has centered around its antioxidant properties. Lutein can build density of the macular pigment, and higher intake of lutein from the diet may play a role in reducing the risk of age-related macular degeneration (ARMD).

Contact: Anne B. Tramer
Selz/Seabolt Communications

Page: 1 2

Related biology news :

1. Dietary supplement shows promise for improving immune function in the elderly
2. Dietary supplement many not lower prostate cancer risk
3. Dietary ginger may work against cancer growth
4. Dietary component kills bacterial cause of ulcers and stomach cancer
5. Dietary soy reduces pain, inflammation in rats
6. Dietary changes can lower colon cancer risk in families with a history of the disease
7. Dietary supplements make old rats youthful, may help rejuvenate aging humans, according to UC Berkeley study
8. Dietary approaches to stop hypertension diet reduces cholesterol and long-term cardiovascular risk
9. Dietary study finds marijuana users have normal nutritional status, risky lifestyle habits
10. Dietary fibre supplements may be harmful
11. Dietary fat itself not likely to cause breast cancer

Post Your Comments:

(Date:8/5/2020)... ... 05, 2020 , ... Regenative Labs has received approval from the Centers for ... them the first Wharton’s jelly allografts to be assigned a Q code and be ... the first Wharton’s jelly allograft product to be recognized as a 361 HCT/P by ...
(Date:7/18/2020)... ... July 16, 2020 , ... A ... of the Invictus Medical Neoasis™ active noise control device to attenuate typical noises ... the Neoasis™ device attenuated the alarm sounds from patient monitors, ventilators and other ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio ... findings of Neihulizumab, a biologic for the treatment of steroid-refractory acute graft-versus-host disease ... hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson Cancer Research Center, this ...
Breaking Biology News(10 mins):
(Date:8/15/2020)... ... August 13, 2020 , ... True Terpenes , the leading ... Scientific Advisory Board (SAB) to research the medical potential of terpenes and the potential ... combined with terpenes. The board is focused on expanding the recently launched line of ...
(Date:8/12/2020)... ... August 11, 2020 , ... The FSHD ... Facioscapulohumeral Muscular Dystrophy Clinical Trial Research Network (FSHD CTRN), with consideration ... is a consortium of academic research centers in the United States and Europe ...
(Date:8/12/2020)... ... 12, 2020 , ... Inc. magazine today revealed that ... compliance consulting has been named on its annual Inc. 5000 list, the most ... look at the most successful companies within the American economy’s most dynamic segment—its ...
(Date:8/3/2020)... ... August 03, 2020 , ... ERT, ... President and CEO has been named one of the 100 most inspiring individuals ... PharmaVoice 100 honorees are selected based on how they have inspired their colleagues ...
Breaking Biology Technology:
Cached News: